SDCPI Immunotherapy Fellows
July 1, 2019-June 30, 2020
Dr. Betzaira Childers
Betzaira G Childers, MD is a general surgery resident at The University of Cincinnati. She has completed two clinical years and is now embarking on a second year in the basic science lab of Dr. Andrew Lowy at UCSD while serving as the SDCPI fellow.
Dr. Childers obtained her medical degree from The University of Texas School of Medicine at San Antonio in 2016. She was a 1500m-5000m track and field specialist
at The University of Texas at Austin and received her degree in biology in 2010. In a recent Oncogene publication, she served as co-author in outlining the role of MST1R Kinase in accelerating pancreatic cancer progression via effects on epithelial cells and macrophages. She is a member of the American College of Surgeons, the Society of Surgical Oncology, and the American Association for Cancer Research. Dr. Childers is interested in finding ways to make immunotherapy more effective in pancreatic cancer as well as identifying and treating complications associated with immunotherapy. She will return to Cincinnati in the summer of 2020 to complete her general surgery training and pursue a career in surgical oncology.
In her spare time, Dr. Childers enjoys spending time with her husband, running, and traveling.
Dr. Peter Vu
Dr. Peter Vu’s research focus is on the development of early phase immunotherapy clinical trials and novel biomarkers under the direction and mentorship of Dr. Sandip Patel. He is completing his fellowship training in hematology and oncology at UC San Diego with a clinical emphasis on thoracic malignancies. He completed his medical residency at Georgetown University and Loyola University and earned his medical degree from Chicago Medical School.
Thank you to Pfizer for supporting our Fellows.
*RFA for 2021 SDCPI Fellows coming soon. For more information: email@example.com